Tag Archives: DNA
By Ben Comer | Published: March 13, 2012
Over a hundred public companies, dozens of clinicians, and several regulators participated in investment firm Leerink Swann’s 2012 Healthcare Conference in mid-February. Press was barred from the event, but John Sullivan, Leerink’s director of research, gives PharmExec a few of the take-aways.
By Audrey Erbes | Published: January 15, 2009
JP Morganâ€™s Healthcare Conference has always been about financing, but money has never been the main focus like it is at this yearâ€™s annual gathering in San Francisco. The hallmark of this investment meeting has been innovation, with companies passionately pitching their new product or technology and management teamâ€™s capability to execute on a business […]